XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Entity Wide Disclosures | 3 Months Ended
--- | ---
Mar. 31, 2018
Revenue From Contract With Customer [Abstract] |
Entity Wide Disclosure | (13) Entity Wide Disclosures Revenue by Category The following table disaggregates our revenue by major source (in thousands):
|  | Three months Ended March 31, 2018 |
Therapeutic Area |  |  |  |
Oncology |  | $ | 43,853 |
Metabolic |  |  | 22,055 |
Cardiology |  |  | 23,736 |
AVAI |  |  | 16,679 |
Endocrine |  |  | 6,458 |
Central Nervous System |  |  | 13,165 |
Medical Devices |  |  | 2,914 |
Other |  |  | 34,217 |
Total Revenue |  | $ | 163,077 |

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration